More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
ICON (ICLR)
Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ICON PLC (NASDAQ: ICLR) (“ICON” or the “Company”) for potential violations of federal securities […]
JetBlue
Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating JetBlue Airways Corporation (NASDAQ: JBLU) (“JetBlue” or the “Company”) for potential breaches of Fiduciary […]
Xponential Fitness
Securities
By Andrea Farah
Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Xponential Fitness, Inc. (NYSE: XPOF) (“Xponential” or the “Company”) for potential violations of federal […]
News
Lowey’s Noelle Feigenbaum Receives 2021 AAI Award for Outstanding Antitrust Litigation Achievement by a Young Lawyer
On November 11, 2021, Noelle Feigenbaum was honored by the American Antitrust Institute ("AAI") with the Outstanding Antitrust Litigation Achievement by a Young Lawyer award, one of two attorneys to receive the award. She was joined at AAI’s 15th annual Private...
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had...